Publish time: 2023-03-17 00:00:00
12A-1091225
US and TW application pending
Previous studies have identified several plasma proteins as biomarkers to detect myocardial infarction; however, this approach is invasive. In this study, the inventors identified that increased abundance of Streptococcus salivarius and Streptococcus parasanguinis in the gut microbial community coincides with the ST-elevation myocardial infarction (STEMI) using metagenome shotgun. The inventor further confirmed with qPCR that detecting the abundance of Streptococcus salivarius and Streptococcus parasanguinis in the human gut microbiota via stool DNA is capable of identifying the STEMI status of the cases. This approach is simple and non-invasive.
- Non-invasive
- Able to identify STEMI with severe loss of heart function
- Development of tools for STEMI detection
- Development of tools for determine the severity of STEMI
- Early diagnosis, prognosis, recurrence and differentiation of MI
Dr. Hsieh, Patrick Ching-Ho
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

METHOD AND BIOMARKER FOR DETECTION OR DIAGNOSIS OF MYOCARDIAL INFARCTION